bosutinib chronic myelogenous leukemia cml drug molecule tyrosine kinase inhibitor targeting bcr abl and src family |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : bosutinib bosutinibe tyrosine kinase inhibitor cancer tumor oncology philadelphia chromosome chronic myelogenous leukemia cml bcrabl src oxygen carbon hydrogen nitrogen chlorine disease drug therapy medicine medicinal product pharmacology pharmacy pharmaceutical pharma treatment generic molecule atoms chemical chemistry composition atomic model molecular |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey), oxygen (red), nitrogen (blue |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2024. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||
